Keywords: biomarin, starts, ph, iii, trial, phenoptin, pharmaceutical

BioMarin starts Ph III trial of Phenoptin

Article | 18 April 2005

Print This

BioMarin Pharmaceutical of the USA says it has randomized the first patient in its Phase III clinical trial of Phenoptin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in